Authors
Dennis Gomez, Marie-Françoise O'Donohue, Thomas Wenner, Céline Douarre, Jérome Macadré, Pascale Koebel, Marie-Josèphe Giraud-Panis, Hervé Kaplan, Alain Kolkes, Kazuo Shin-Ya, Jean-François Riou
Publication date
2006/7/15
Journal
Cancer research
Volume
66
Issue
14
Pages
6908-6912
Publisher
American Association for Cancer Research
Description
Telomestatin is a potent G-quadruplex ligand that specifically interacts with the 3′ telomeric overhang, leading to its degradation and that induces a delayed senescence and apoptosis of cancer cells. Protection of Telomere 1 (POT1) was recently identified as a specific single-stranded telomere-binding protein involved in telomere capping and T-loop maintenance. We showed here that a telomestatin treatment inhibits POT1 binding to the telomeric overhang in vitro. The treatment of human EcR293 cells by telomestatin induces a dramatic and rapid delocalization of POT1 from its normal telomere sites but does not affect the telomere localization of the double-stranded telomere-binding protein TRF2. Thus, we propose that G-quadruplex stabilization at telomeric G-overhang inactivates POT1 telomeric function, generating a telomere dysfunction in which chromosome ends are no longer properly protected …
Total citations
20062007200820092010201120122013201420152016201720182019202020212022202320242243027232114141313171410488233